Skip to main content

Envisioning is an emerging technology research institute and advisory.

LinkedInInstagramGitHub

2011 — 2026

research
  • Observatory
  • Newsletter
  • Methodology
  • Origins
  • Vocab
services
  • Signals Session
  • Bespoke Projects
  • Build Sessions
  • Use Cases
  • Readinessfree
  • Signals
  • Free scan↗free
impact
  • ANBIMAFuture of Brazilian Capital Markets
  • IEEECharting the Energy Transition
  • Horizon 2045Future of Human and Planetary Security
  • WKOTechnology Scanning for Austria
solutions
  • Innovation
  • Strategy
  • Consultants
  • Foresight
  • Associations
  • Governments
resources
  • Partners
  • Coding for Non-Coders
  • How We Work
  • Data Visualization
  • Multi-Model Method
  • FAQ
  • Security & Privacy
about
  • Manifesto
  • Community
  • Events
  • Support
  • Contact
ResearchServicesSignalsAbout
ResearchServicesSignalsAbout
  1. Home
  2. Research
  3. Helix
  4. Systemic Milieu Reset Protocols

Systemic Milieu Reset Protocols

Plasmapheresis and plasma-mimetic therapies to rebalance pro- and anti-aging factors.
Back to HelixView interactive version

Systemic milieu reset protocols are clinical treatment programs that combine therapeutic plasma exchange (removing and replacing blood plasma), albumin replacement, and young-plasma mimetic infusions (solutions that mimic the composition of young blood plasma) to dilute pro-aging circulating factors (substances in the blood that promote aging) and restore regenerative signaling (biological signals that promote tissue repair and regeneration). These systemic interventions aim to reset the body's internal environment to a more youthful state, potentially improving cognition, cardiovascular health, and frailty metrics without requiring chronic drug exposure, representing a comprehensive approach to addressing aging at the systemic level. Clinics and research institutions are developing these protocols.

This innovation addresses research suggesting that factors in the blood change with age and contribute to aging, where resetting the blood composition could potentially have rejuvenating effects. By combining multiple approaches to modify the blood environment, these protocols aim to create comprehensive systemic effects. However, the scientific basis and effectiveness remain areas of active research.

The technology is being explored for longevity applications, where systemic interventions could potentially address multiple aspects of aging simultaneously. As research progresses, these protocols could become more established. However, ensuring safety, demonstrating effectiveness, and managing costs remain challenges. The technology represents an interesting approach to anti-aging interventions, but requires continued research to establish efficacy and safety. Success could provide new options for healthy aging, but the scientific basis needs further validation and the approach must be carefully evaluated for safety and effectiveness.

TRL
4/9Formative
Impact
4/5
Investment
4/5
Category
Applications

Related Organizations

Alkahest logo
Alkahest

United States · Company

95%

Biotech company identifying proteins in plasma that change with age to develop targeted therapies.

Developer
Grifols logo
Grifols

Spain · Company

95%

Global healthcare company and producer of plasma-derived medicines.

Developer
UC Berkeley logo
UC Berkeley

United States · University

95%

Home to the Conboy Lab (Irina and Michael Conboy).

Researcher
Lyfspn logo
Lyfspn

United States · Startup

90%

Organization founded by Dr. Dobri Kiprov focusing on therapeutic plasma exchange for longevity.

Deployer
Stanford University logo
Stanford University

United States · University

90%

The Vuckovic Group develops inverse-designed photonics for quantum frequency conversion.

Researcher
Global Apheresis

United States · Company

85%

Clinical center specializing in therapeutic apheresis and immunopheresis.

Deployer
Elevian logo
Elevian

United States · Startup

80%

Developing medicines that restore youthful regenerative capacity, focusing on GDF11.

Developer
Young Blood Institute logo
Young Blood Institute

United States · Nonprofit

80%

A non-profit corporation researching new uses for Therapeutic Plasma Exchange.

Researcher
Fountain Therapeutics

United States · Startup

75%

Uses AI to identify cellular age reversal therapeutics.

Developer

Supporting Evidence

Evidence data is not available for this technology yet.

Research this in Signals

Scan Systemic Milieu Reset Protocols for yourself.

Signals turns a topic into a sourced research record you can inspect and rerun. Your first scan is free, and this one starts with Systemic Milieu Reset Protocols already loaded, so edit it or scan as is.